Trendingnow
Big Tech

By Norah Rami, Matthew Griffin and BloombergAugust 29, 2026

Forget GLP-1 stocks, baldness drugs are Wall Street’s next goldmine
By Avalon Pernell, Lisa Pham and BloombergAugust 29, 2026

Latest stories from Fortune
More Big TechPage 6 of 73

By Marco Quiroz-GutierrezJuly 31, 2026

By Amanda GerutJuly 30, 2026

By Alexei OreskovicJuly 30, 2026

By Nick LichtenbergJuly 30, 2026

By Amanda GerutJuly 30, 2026

By Eva RoytburgJuly 30, 2026

By Sarah GlodekJuly 30, 2026

By Preston ForeJuly 30, 2026

By Stan Choe and The Associated PressJuly 30, 2026

By Barbara Ortutay and The Associated PressJuly 30, 2026

By Kim Tong-Hyung and The Associated PressJuly 30, 2026

By Shawn TullyJuly 30, 2026

By Eva RoytburgJuly 29, 2026

By Amanda GerutJuly 29, 2026

By Beatrice NolanJuly 29, 2026

By Catherina GioinoJuly 29, 2026

By Angelica AngJuly 28, 2026

By Eva RoytburgJuly 28, 2026

By Tatiana SatauaJuly 28, 2026

By Mia OsmonbekovJuly 28, 2026
By Kristin StollerJuly 28, 2026
By Nicholas GordonJuly 28, 2026

By Emily ForliniJuly 27, 2026

By Jason MaJuly 27, 2026

By The Associated PressJuly 27, 2026

By Amanda GerutJuly 27, 2026

By Nick LichtenbergJuly 27, 2026

By Jeran Wittenstein, Ryan Vlastelica and BloombergJuly 26, 2026
Most Popular















